[放射性药物不良反应调查报告第43号（2020年第46次调查）]

[The 43rd Report on the Survey of Adverse Reactions to Radiopharmaceuticals (46th Survey in 2020)].

作者信息

Okazawa Hidehiko, Uehara Tomoya, Kuji Ichiei, Higashi Tatsuya, Yoshimura Mana

机构信息

Biomedical Imaging Research Center, University of Fukui.

Graduate School of Pharmaceutical Sciences, Chiba University.

出版信息

Kaku Igaku. 2022;59(1):1-12. doi: 10.18893/kakuigaku.rp.2231.

DOI:10.18893/kakuigaku.rp.2231

PMID:35321966

Abstract

This survey was performed to investigate the incidence of adverse reactions to radiopharmaceuticals in FY2020 in Japan. The results are based on responses to questionnaires sent to nuclear medicine centers. Replies were obtained from 1,006 centers out of 1,212 to which the questionnaire was sent. A total of 940,758 administrations of radiopharmaceuticals were reported. There were 17 cases with adverse reactions, giving an incidence of adverse reactions of 1.8 per 100,000 cases. Two cases of defective products were reported, giving an incidence of defective products of 0.2 per 100,000 cases.

摘要

本次调查旨在研究2020财年日本放射性药物不良反应的发生率。结果基于向核医学中心发送的调查问卷的回复。在1212个被发送调查问卷的中心中，有1006个中心进行了回复。总共报告了940,758次放射性药物给药。有17例出现不良反应，不良反应发生率为每10万例1.8例。报告了2例产品缺陷案例，产品缺陷发生率为每10万例0.2例。